Brill Earth BRLT Q1 2026 Disappoints EPS 005 Below 004 Views Samsung Strike Involving 47000 Workers Looms as South Koreas President Urges Labor Deal KBR KBR Delivers Q1 2026 Beat EPS 096 vs 092 Expected Nifty 42000 by 2028 A New Study Suggests Its PossibleHeres What Needs to Align Novartis Lifts Annual Sales and Profit Forecast Amid Strong Operational Momentum Beyond Energy Consumer Prices Reaccelerating Across Multiple Sectors Caribbean Real Estate Dispute Foreign Buyers and Beach Access Concerns in Barbuda Grenada and Jamaica UK Police Chiefs Propose AgeRestriction on Unsafe Social Media Platforms for Under16s New Tax Season Rules for Online Sellers and EV Owners May Offer Savings Cigna Group CI Draws Analyst Upgrade Amid Dividend Growth and Managed Care Tailwinds APAM Q1 2026 Earnings EPS Misses Consensus as Market Headwinds Persist ANET Q1 2026 Earnings Strong EPS Beat Drives Stock Higher Winmark Corporation WINA Q1 2026 Earnings EPS Misses Estimates Amid Margin Headwinds TOST Q1 2026 Earnings Profitability Surprise Drives Modest Stock Uptick CGAU Q1 2026 Earnings EPS Misses Estimates Amid Mixed Gold Market Conditions PRVA Q1 2026 Earnings Profit Miss Overshadowed by Slight Stock Gain Global Industrial Company GIC Gains Ground as Support Holds Resistance in Focus Activate Energy Acquisition Corp Warrant AEAQW Edges Higher Amid Speculative Interest VCI Global VCIG Skyrockets 6479 Surge Tests Key Resistance at 140 Exxon Mobil XOM Holds Steady Near 155 as Energy Sector Faces Mixed Signals Prologis PLD Edges Higher as Industrial REITs Gain Traction Amid Modest Gains GOLD Q1 2026 Earnings EPS Crushes Estimates with 61 Surprise Yet Stock Dips PRTA Q1 2026 Earnings Biotech Surprises with Positive EPS on Milestone Gain Stock Rises NAGE Q1 2026 Earnings Modest EPS Beat Amid Limited Revenue Disclosure WHD Q1 2026 Earnings EPS Beat Fails to Lift Shares Amid Market Caution TRIN Q1 2026 Earnings EPS Beats Estimates by 116 Shares Decline Slightly Retailers Accelerate Hiring Amid Cautious Consumer Outlook ATNI Q1 2026 Earnings Significant EPS Miss Amid Challenging Quarter Intellia Therapeutics Slides Slightly Amid Cautious Trading in GeneEditing Sector